Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids

Clinical trial NCT07610616 · RECRUITING

Trial details

NCT number: NCT07610616
Sponsor: Guangzhou Institute of Respiratory Disease
Status: RECRUITING
Study type: OBSERVATIONAL

HER2 Positive OR TROP2 Positive Non-Small Cell Lung Cancer

Start date: 2025-12-28
Primary completion: 2027-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.